Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Arizona Man Latest to Claim Actos Caused Bladder Cancer

Filed June 13th, 2013 Joshua Sophy

An Arizona man claims taking the type 2 diabetes drug Actos caused him to develop bladder cancer.

His complaint against the drugmakers, Takeda Pharmaceuticals and Eli Lilly and Co., is the latest to be filed by someone who was prescribed the drug to regulate symptoms of diabetes. The lawsuit was filed in the U.S. District Court for the Western District of Louisiana. There, it joins thousands more lawsuits which all make similar claims, as part of a multidistrict litigation (MDL).
Like those other lawsuits, the latest representing the Arizona man claims that he was not warned of the risk of bladder cancer associated with Actos. The complaint alleges that the drug makers were aware of this risk but failed to warn the public, according to an announcement from the national law firm of Parker Waichman LLP, which represents this victim and a growing number of other victims of Actos-related bladder cancer.

The Arizona man claims he began taking Actos in March 2003. He was diagnosed more than five years later, in November 2008, with bladder cancer.

Two years ago, the U.S. Food and Drug Administration (FDA) warned that taking Actos for more than a year or at high doses significantly increased a person’s chances of developing bladder cancer. Since that announcement, more and more people who’ve been taking Actos have come forward and linked their bladder cancer diagnosis to taking the diabetes drug for so long.

According to our previous reports, there have been several other studies which have quantified the risk of bladder cancer linked to Actos. Last year, a study appearing in the British Medical Journal revealed that people taking Actos for more than a year were doubling their risk of developing bladder cancer.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!